151 related articles for article (PubMed ID: 11369657)
1. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia.
van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; van der Holt B; Vossebeld PJ; Pieters R; Sonneveld P
Blood; 2001 Jun; 97(11):3605-11. PubMed ID: 11369657
[TBL] [Abstract][Full Text] [Related]
2. MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.
van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; Slater RM; Smit EM; van Noesel MM; van der Holt B; Schoester M; Pieters R; Sonneveld P
Leukemia; 2001 Mar; 15(3):398-405. PubMed ID: 11237063
[TBL] [Abstract][Full Text] [Related]
3. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
van der Kolk DM; de Vries EG; Noordhoek L; van den Berg E; van der Pol MA; Müller M; Vellenga E
Leukemia; 2001 Oct; 15(10):1544-53. PubMed ID: 11587212
[TBL] [Abstract][Full Text] [Related]
4. MDR1/P-GP expression as a prognostic factor in acute leukemias.
Marie JP; Legrand O
Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
6. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
[TBL] [Abstract][Full Text] [Related]
7. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
[TBL] [Abstract][Full Text] [Related]
8. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides.
Motomura S; Motoji T; Takanashi M; Wang YH; Shiozaki H; Sugawara I; Aikawa E; Tomida A; Tsuruo T; Kanda N; Mizoguchi H
Blood; 1998 May; 91(9):3163-71. PubMed ID: 9558371
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
11. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
[TBL] [Abstract][Full Text] [Related]
12. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis.
Kaltoum ABO; Sellama N; Hind D; Yaya K; Mouna L; Asma Q
Curr Res Transl Med; 2020 Jan; 68(1):29-35. PubMed ID: 31307954
[TBL] [Abstract][Full Text] [Related]
13. Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India.
Rao DN; Anuradha C; Vishnupriya S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S
Asian Pac J Cancer Prev; 2010; 11(4):1063-6. PubMed ID: 21133625
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.
Egashira M; Kawamata N; Sugimoto K; Kaneko T; Oshimi K
Blood; 1999 Jan; 93(2):599-606. PubMed ID: 9885221
[TBL] [Abstract][Full Text] [Related]
16. Discordance of P-glycoprotein expression and function in acute leukemia.
De Moerloose B; Dhooge C; Philippé J
Adv Exp Med Biol; 1999; 457():107-18. PubMed ID: 10500786
[TBL] [Abstract][Full Text] [Related]
17. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
Hegewisch-Becker S; Staib F; Löning T; Pichlmeier U; Kröger N; Reymann A; Hossfeld DK
Ann Oncol; 1998 Jan; 9(1):85-93. PubMed ID: 9541688
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of P-gp expression and related function in childhood acute leukemia.
Karakaş Z; Ağaoğlu L; Erdem S; Demirel GY; Arasa M; Süzergöz F; Deniz G; Anak S; Gedikoğlu G
Adv Exp Med Biol; 1999; 457():21-8. PubMed ID: 10500776
[No Abstract] [Full Text] [Related]
19. Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC).
Advani R; Visani G; Milligan D; Saba H; Tallman M; Rowe JM; Wiernik PH; Ramek J; Dugan K; Lum B; Villena J; Davis E; Paietta E; Litchman M; Covelli A; Sikic B; Greenberg P
Adv Exp Med Biol; 1999; 457():47-56. PubMed ID: 10500779
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.
Dhooge C; De Moerloose B
Adv Exp Med Biol; 1999; 457():11-9. PubMed ID: 10500775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]